Stratus Therapeutics
Wenjian (Jane) Lv is a seasoned scientist with extensive experience in the biotechnology field. Currently serving as a Senior Scientist II at Garuda Therapeutics since April 2024, Wenjian has held previous positions as a Senior Scientist at Clade Therapeutics and as a Scientist at Century Therapeutics, Inc. from September 2021 to April 2024. Prior to this, Wenjian was a Research Associate at the University of Pennsylvania and completed a Postdoctoral Fellowship at Harvard University after serving as a Postdoctoral Scientist at Cedars-Sinai. Wenjian earned a Doctor of Philosophy (PhD) in Biology from the Shanghai Institute of Biochemistry and Cell Biology, completing the degree in July 2013.
Stratus Therapeutics
4 followers
Stratus Therapeutics is redefining regenerative medicine with Stratus Prime™ — a platform for full hematopoietic system renewal, on demand. Our proprietary product, ST-101, includes both hematopoietic stem cells (Prime HSCs™) and hematopoietic progenitor cells (Prime HPCs™) to drive durable, long-term engraftment with full hematopoietic system restoration, while supporting near-term immune reconstitution.